Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults

BMC Family Practice

Volumn 16, Issue 1, 2015, Pages

  Jansen, Jesse ^a,b   McKinn, Shannon ^a,b   Bonner, Carissa ^a,b   Irwig, Les ^a   Doust, Jenny ^a,c   Glasziou, Paul ^a,c   Nickel, Brooke ^a,b   Van Munster, Barbara ^d,e   McCaffery, Kirsten ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BOND UNIVERSITY   (Australia)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e GELRE HOSPITALS   (Netherlands)

Author keywords

Aging; Cardiovascular diseases; Guidelines; Shared decision making

Indexed keywords

AGED; CARDIOVASCULAR DISEASES; HUMAN; PRACTICE GUIDELINE; PRIMARY PREVENTION; STANDARDS;

AGED; CARDIOVASCULAR DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION;

EID: 84939496892     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-015-0310-1     Document Type: Article

References (51)

1. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Jama. 2005;294:716-24.
2. Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med. 2010;170:587-95.
3. Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Australas J Ageing. 2002;21:58-60.
4. American Geriatrics Society. Expert Panel on the Care of Older Adults with Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society. J Am Geriatr Soc. 2012;60:1957-68.
5. Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9, e83783.
6. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43.
7. National Seniors Productive Ageing Centre. Senior Australians and prescription medicines: usage, sources of information and affordability. Canberra: Department of Health and Ageing; 2012.
8. National Center for Health Statistics. Health, United States: 2013: With Special Feature on Prescription Drugs. Hyattsville, MD: U.S. Department of Health and Human Services; 2014.
9. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989-95.
10. Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870-4.
11. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-9.
12. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: A systematic review. JAMA. 2012;307:182-92.
13. Fried TR, Tinetti ME, Iannone L, O'Leary JR, Towle V, Van Ness PH. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011;171:1854-6.
14. Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008;56:1839-44.
15. Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc. 2008;56:1409-16.
16. Fried TR, O'Leary J, Van Ness P, Fraenkel L. Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc. 2007;55:1007-14.
17. Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86:9-18.
18. Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care. 2000;38:335-41.
19. Laidsaar-Powell RC, Butow PN, Bu S, Charles C, Gafni A, Lam WWT, et al. Physician-patient-companion communication and decision-making: A systematic review of triadic medical consultations. Patient Educ Couns. 2013;91:3-13.
20. van der Weijden T, Pieterse AH, Koelewijn-van Loon MS, Knaapen L, Légaré F, Boivin A, et al. How can clinical practice guidelines be adapted to facilitate shared decision making? A qualitative key-informant study. BMJ Quality & Safety. 2013;22:855-63.
21. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39:674-80.
22. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension. The National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105-14.
23. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, et al. Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med. 2010;170:27-40.
24. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation. 2008;117:743-53.
25. Jackson R. Cardiovascular risk prediction: are we there yet? Heart. 2008;94:1-3.
26. Liew SM, Jackson R, Mant D, Glasziou P. Should identical CVD risks in young and old patients be managed identically? Results from two models. BMJ Open. 2012;2, e000728.
27. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-98.
28. Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, et al. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to hypertension in the very elderly randomised controlled trial. BMJ. 2012;344:d7541.
29. Baigent C, Keech A. Kearney PMa, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Cholesterol Treatment Trialists'(CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.
30. Savarese G, Gotto Jr AM, Paolillo S, D'Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013;62:2090-9.
31. Tinetti ME, Han L, McAvay GJ, Lee DSH, Peduzzi P, Dodson JA, et al. Anti-hypertensive medications and cardiovascular events in older adults with multiple chronic conditions. PLoS One. 2014;9, e90733.
32. Hilmer SG, Gnjidic D. Statins in older adults. Aust Prescr. 2013;36:79-82.
33. Naganathan V. Cardiovascular drugs in older people. Aust Prescr. 2013;36:190-4.
34. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int. 2013;24:2649-57.
35. Weiner M, Wells S, Kerse N. Perspectives of general practitioners towards evaluation and treatment of cardiovascular disease among older people. J Primary Health Care. 2009;1:198-206.
36. Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust. 2008;189:360-5.
37. Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011;57:e253-62.
38. Moschetti I, Brandt D, Perera R, Clarke M, Heneghan C. Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: systematic review. BMJ. 2011;342:d1289.
39. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 67: Lipid modification - Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Clinical Excellence; 2010.
40. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007;28:1462-536.
41. Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602-12.
42. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 127: Hypertension. Clinical management of primary hypertension in adults. London: National Institute for Health and Clinical Excellence; 2011.
43. McMillan GJ, Hubbard RE. Frailty in older inpatients: what physicians need to know. QJM. 2012;105:1059-65.
44. Fried TR, Tinetti ME, Towle V, O'Leary JR, Iannone L. Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med. 2011;171:923-8.
45. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648-54.
46. Wyatt KD, Stuart LM, Brito JP, Carranza Leon B, Domecq JP, Prutsky GJ, et al. Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review. Med Care. 2014;52 Suppl 3:S92-s100.
47. JBS3 Board. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100:ii1-ii67.
48. National Institute for Health and Care Excellence. NICE Clinical Guideline CG181:Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence; 2014.
49. James PA, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in Adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20.
50. Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345, e6341.
51. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PKJ, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13:S7.